LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2020-12-31

Reporting Person: Invus C.V. (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-31	Common Stock	J	4321214	—	Disposed	0	Direct

Footnotes

F1: On December 31, 2020, Invus C.V. dissolved and transferred the shares of Class A common stock of the Issuer held by it to Invus Partners, LLC.